Table of Contents
Table 5-91: White
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2003 | 1999 - 2003 | 2003 | 1999 - 2003 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 63 | 427.0 | 281 | 398.2 | 36 | 264.5 | 164 | 243.9 |
| Esophagus | * | # | 11 | 15.1** | * | # | 9 | 12.9** |
| Stomach | * | # | 5 | 7.2** | * | # | 2 | # |
| Colon excluding Rectum | 8 | 56.8** | 23 | 35.0 | * | # | 17 | 28.0** |
| Rectum and Rectosigmoid Junction | * | # | 18 | 25.9** | * | # | 3 | # |
| Liver | * | # | 3 | # | * | # | 2 | # |
| Pancreas | * | # | 7 | 10.2** | * | # | 4 | # |
| Lung and Bronchus | 14 | 101.1** | 57 | 81.3 | 9 | 64.5** | 56 | 81.1 |
| Melanoma of the Skin | * | # | 8 | 11.2** | * | # | 2 | # |
| Prostate | 12 | 82.0** | 46 | 64.9 | 8 | 62.9** | 17 | 27.5** |
| Urinary Bladder | 8 | 54.1** | 22 | 31.2 | * | # | 4 | # |
| Kidney and Renal Pelvis | * | # | 14 | 19.3** | * | # | 5 | 7.4** |
| Brain and Other Nervous System | * | # | 7 | 9.1** | * | # | 4 | # |
| Non-Hodgkin Lymphoma | * | # | 10 | 14.8** | * | # | 8 | 11.9** |
| Myeloma | * | # | 4 | # | * | # | 2 | # |
| Leukemia | * | # | 14 | 20.4** | * | # | 13 | 19.1** |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2003 | 1999 - 2003 | 2003 | 1999 - 2003 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 82 | 454.9 | 378 | 430.1 | 33 | 170.5 | 153 | 166.9 |
| Colon excluding Rectum | 7 | 40.2** | 40 | 43.8 | * | # | 21 | 21.6 |
| Rectum and Rectosigmoid Junction | * | # | 18 | 19.6** | * | # | 3 | # |
| Liver | * | # | 0 | # | * | # | 1 | # |
| Pancreas | * | # | 10 | 10.2** | * | # | 8 | 8.5** |
| Lung and Bronchus | 15 | 79.1** | 56 | 63.3 | 6 | 33.0** | 34 | 38.2 |
| Melanoma of the Skin | * | # | 5 | 5.9** | * | # | 1 | # |
| Breast | 22 | 124.7 | 120 | 139.1 | 7 | 37.9** | 25 | 27.3 |
| Cervix Uteri | * | # | 6 | 7.4** | * | # | 1 | # |
| Corpus Uteri | 6 | 31.5** | 26 | 30.1 | * | # | 1 | # |
| Ovary | 6 | 36.4** | 14 | 16.9** | * | # | 12 | 13.7** |
| Urinary Bladder | * | # | 7 | 7.7** | * | # | 2 | # |
| Kidney and Renal Pelvis | * | # | 6 | 7.2** | * | # | 1 | # |
| Brain and Other Nervous System | * | # | 3 | # | * | # | 3 | # |
| Non-Hodgkin Lymphoma | 5 | 29.7** | 16 | 18.0** | * | # | 8 | 8.8** |
| Myeloma | * | # | 0 | # | * | # | 2 | # |
| Leukemia | * | # | 6 | 7.2** | * | # | 6 | 6.1** |
Rates are per 100,000; Age-adjusted, 2000 US Std Population (Census P25-1130).
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, July 2006
Table of Contents
Table 5-91: White
